These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2328763)

  • 1. A novel dibenzoxazepine derivative (BY-1949) increases regional cerebral blood flow.
    Sugawa M; Koide T; Kohda A; Takato M
    Eur J Pharmacol; 1990 Mar; 178(2):225-8. PubMed ID: 2328763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Valikovics A
    Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of BY-1949 on evoked responses of cortical blood flow and Meynert neurons.
    Takao A; Tohru K; Michiaki T; Shinji H
    Eur J Pharmacol; 1992 Jun; 217(1):101-4. PubMed ID: 1397022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
    Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
    Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
    Tamaki N; Matsumoto S
    Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of VA-045 on peripheral and central circulation in anesthetized dogs.
    Yamada S; Yamaguchi K; Okuyama S
    Gen Pharmacol; 1995 Oct; 26(6):1419-24. PubMed ID: 7590141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of vinpocetine against brain damage caused by ischemia.
    Rischke R; Krieglstein J
    Jpn J Pharmacol; 1991 Jul; 56(3):349-56. PubMed ID: 1895579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of VA-045, a novel apovincaminic acid derivative, on age-related impairment evidence in electroencephalograph, caudate spindle, a passive avoidance task and cerebral blood flow in rats.
    Okuyama S; Hashimoto-Kitsukawa S; Ogawa S; Imagawa Y; Kawashima K; Kawashima Y; Araki H; Otomo S
    Gen Pharmacol; 1994 Nov; 25(7):1311-20. PubMed ID: 7896040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cavinton forte on the cerebral hemodynamic and autoregulation mechanisms of cerebral blood flow in patients with chronic cerebral ischemia].
    Grigor'eva AN; Nesterova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):90-1. PubMed ID: 19708280
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measurements of regional brain blood flow using xenon 133 before and after intravenous administration of the so-called vasoactive and cerebral-metabolism-active drugs in acute experiment].
    Kohlmeyer K
    Verh Dtsch Ges Kreislaufforsch; 1973; 39():96-101. PubMed ID: 4785972
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of action of vinpocetine].
    Kiss B; Kárpáti E
    Acta Pharm Hung; 1996 Sep; 66(5):213-24. PubMed ID: 9082841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates.
    Kawashima Y; Ikemoto T; Horiguchi A; Hayashi M; Matsumoto K; Kawarasaki K; Yamazaki R; Okuyama S; Hatayama K
    J Med Chem; 1993 Apr; 36(7):815-9. PubMed ID: 8464035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral circulatory and metabolic drugs.
    Aurousseau M; Albert O
    Eur Neurol; 1978; 17 Suppl 1():73-86. PubMed ID: 753641
    [No Abstract]   [Full Text] [Related]  

  • 14. BY-1949 elicits vasodilation via preferential elevation of cyclic GMP levels within the cerebral artery: possible involvement of endothelium-mediated mechanisms.
    Sugawa M; Koide T; Takato M
    Eur J Pharmacol; 1992 Apr; 215(1):57-62. PubMed ID: 1325363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General and cerebral haemodynamic activity of ethyl apovincaminate.
    Kárpáti E; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1908-12. PubMed ID: 1037212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinpocetine prevents ischemic cell damage in rat hippocampus.
    Sauer D; Rischke R; Beck T; Rossberg C; Mennel HD; Bielenberg GW; Krieglstein J
    Life Sci; 1988; 43(21):1733-9. PubMed ID: 3193857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of corglycon and cavinton on the hemodynamics of patients with initial manifestations of insufficiency of cerebral circulation].
    Ishchenko MM; Nechaĭ EE
    Vrach Delo; 1988 May; (5):53-5. PubMed ID: 3420871
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
    Tamaki N; Kusunoki T; Matsumoto S
    Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral metabolic, hemodynamic and antihypoxic properties of l-eburnamonine.
    Linée P; Lacroix P; Le Polles JB; Aurousseau M; Boulu R; Van den Driessche J; Albert O
    Eur Neurol; 1978; 17 Suppl 1():113-20. PubMed ID: 753626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
    Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B
    J Neurol Sci; 2005 Mar; 229-230():275-84. PubMed ID: 15760651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.